Research graph
References from Real-world safety of dengue vaccines in Brazil: A pharmacovigilance study. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Unresolved reference
External reference
Dengue virus: epidemiology, biology, and disease aetiology
10.1139/cjm-2020-0572 · 2021 · External reference
Reemergence of dengue virus serotype 3, Brazil, 2023
10.3201/eid2907.230595 · 2023 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Three dengue vaccines - what now?
10.1056/nejme2314240 · 2024 · External reference
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial
10.1016/s2214-109x(23)00522-3 · 2024 · External reference
Efficacy of a tetravalent dengue vaccine in healthy children and adolescents
10.1056/nejmoa1903869 · 2019 · External reference
Live, attenuated, tetravalent Butantan–dengue vaccine in children and adults
10.1056/nejmoa2301790 · 2024 · External reference
Effectiveness of mass dengue vaccination with CYD-TDV (Dengvaxia®) in the state of Paraná, Brazil: integrating case-cohort and case-control designs
2024 · External reference
10.7189/jogh.08.020312
10.7189/jogh.08.020312 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
COVID-19 mRNA vaccines: a retrospective observational pharmacovigilance study
10.1007/s40261-022-01216-9 · 2022 · External reference
Pharmacovigilance in vaccines: importance, main aspects, perspectives, and challenges—a narrative review
10.3390/ph17060807 · 2024 · External reference
Unresolved reference
External reference
Safety signal detected: anaphylaxis after attenuated dengue vaccine (TAK-003) - Brazil, march 1, 2023-march 11, 2024
10.1016/j.vaccine.2024.126407 · 2024 · External reference
Adverse events and immunization errors following a mass immunization campaign with TAK-003 in Dourados, Brazil: a post-marketing safety surveillance analysis
10.1002/jmv.70674 · 2025 · External reference
Sex and gender differences in the outcomes of vaccination over the life course
10.1146/annurev-cellbio-100616-060718 · 2017 · External reference
Influenza vaccination coverage among persons ages six months and older in the vaccine safety datalink in the 2017–18 through 2022–23 influenza seasons
10.1016/j.vaccine.2023.10.023 · 2023 · External reference
Unresolved reference
External reference
10.1016/j.vaccine.2019.11.078
10.1016/j.vaccine.2019.11.078 · External reference
Vaccine safety: current systems and recent findings
10.1097/mop.0b013e3283350425 · 2010 · External reference
O subfinanciamento do Sistema Único de Saúde e seus rebatimentos no enfrentamento da Covid-19
10.1590/s0103-73312020300313 · 2020 · External reference
O trabalho da enfermagem na imunização no contexto da crise sanitária brasileira
2021 · External reference
Danos à saúde dos trabalhadores de enfermagem de salas de vacinação
10.37689/acta-ape/2020ao0147 · 2020 · External reference
Construction and validity of an educational video to prevent immunization errors
2023 · External reference
Unresolved reference
External reference
10.22239/2317-269x.02319
10.22239/2317-269x.02319 · External reference
Unresolved reference
External reference
10.26633/rpsp.2025.1
10.26633/rpsp.2025.1 · External reference
Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to august 2021
10.1001/jama.2021.24110 · 2022 · External reference
10.36660/abc.20220331
10.36660/abc.20220331 · 2022 · External reference
Farmacovigilância de vacinas contra COVID-19 no Brasil: ações realizadas, lições aprendidas e próximos passos
10.26633/rpsp.2025.1 · 2025 · External reference
The anti-vaccination movement: a regression in modern medicine
2018 · External reference
10.1080/21645515.2021.1955607
10.1080/21645515.2021.1955607 · External reference
Acceptance of a dengue vaccine and potential change in vector control behavior
2025 · External reference
10.3390/vaccines13050516
10.3390/vaccines13050516 · External reference
